Results 91 to 100 of about 343 (127)

Evolving Food Allergy Clinical Trials to Become More Patient-Centered. [PDF]

open access: yesJ Allergy Clin Immunol Pract
Dantzer JA, Shaker MS, Greenhawt M.
europepmc   +1 more source

Evaluation of health-related quality of life changes in an Australian rapid access chest pain clinic. [PDF]

open access: yesBMC Health Serv Res
Black JA   +7 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Psychometric properties of the SF-6Dv2 in an Iranian breast cancer population

Breast Cancer, 2021
The Short-Form Six-Dimension version 2 (SF-6Dv2) is the newest preference-based instrument for estimation of quality adjusted life-years (QALYs). The aim of this study is to evaluate the validity and reliability of the SF-6Dv2 in an Iranian breast cancer population.The SF-6Dv2 and FACT-B instruments were completed for 416 patients who were recruited ...
Azin Nahvijou   +2 more
exaly   +3 more sources

Valuing SF-6Dv2 in Australia Using an International Protocol

Pharmacoeconomics, 2021
The SF-6Dv2 is an updated version of the SF-6D, with improved consistency and dimension descriptors, and value sets are required. The aim of this study was to estimate an SF-6Dv2 value set for Australia using an international protocol, while secondary aims were to compare Australian and UK values and to understand heterogeneity.The study design was ...
Brendan Mulhern   +2 more
exaly   +3 more sources

Population Norms for SF-6Dv2 and EQ-5D-5L in China

Applied Health Economics and Health Policy, 2022
To derive the population norms for EQ-5D-5L and SF-6Dv2 among the Chinese general population.Data collected alongside the Chinese SF-6Dv2 valuation study conducted between June and September 2019 were used. SF-6Dv2 and EQ-5D-5L, as well as social-demographic characteristics and self-reported chronic conditions, were collected through face-to-face ...
Shitong Xie, Jing Wu, Feng Xie
exaly   +3 more sources

Exploring the consistency of the SF-6Dv2 in a breast cancer population

Expert Review of Pharmacoeconomics & Outcomes Research, 2020
Background: Short-Form Six-Dimension version 2 (SF-6Dv2) is a multi-attribute utility instrument that can be used in combination with the SF-36v2 (SF-6Dv2SF-36) or as an independent instrument in two forms: six questions (SF-6Dv2ind-6) and 10 questions (SF-6Dv2ind-10).
Hosein Ameri   +2 more
openaire   +2 more sources

Eliciting SF-6Dv2 health state utilities using an anchored best-worst scaling technique

Social Science and Medicine, 2021
There is an increasing interest in using ordinal data collection methods, such as the best-worst scaling (BWS), to develop preference-based tariffs (value sets) for health-related quality of life instruments, yet the evidence on their performance is limited.
A Osman, Jing Wu, Gang Chen
exaly   +3 more sources

Psychometric performance of EQ-5D-5L and SF-6Dv2 in patients with lymphoma in China

open access: yesEuropean Journal of Health Economics
To assess and compare the measurement properties of EQ-5D-5L and SF-6Dv2 among lymphoma patients in China.A face-to-face survey of Chinese lymphoma patients was conducted at baseline (all types) and follow-up (diffuse large B-cell). EQ-5D-5L and SF-6Dv2 health utility scores (HUSs) were calculated using the respective Chinese value sets. Ceiling effect
Zhuxin Mao, Nan Luo, Pei Wang
exaly   +4 more sources

Home - About - Disclaimer - Privacy